About
News, Events & Presentations
Press Releases | Events Calendar | Presentations

Keyword Search
 
2017 | 2016 | 2015 | 2014
DateTitle 
11/05/15Fibrocell Science Reports Third Quarter 2015 Financial Results and Operational HighlightsPrinter Friendly Version
10/29/15Fibrocell to Report Third Quarter 2015 Financial and Operating Results, and Host Conference Call and Webcast on Thursday, November 5, 2015Printer Friendly Version
10/08/15Fibrocell and Intrexon Announce Poster Presentation on FCX-007 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB) at American Society of Human Genetics Annual MeetingPrinter Friendly Version
10/01/15Fibrocell to Present at 2015 Stem Cell Meeting on the MesaPrinter Friendly Version
09/25/15Fibrocell and Intrexon Provide Regulatory Update for FCX-007 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)Printer Friendly Version
09/03/15Fibrocell to Present at Multiple Investor Conferences in SeptemberPrinter Friendly Version
08/06/15Fibrocell Science Reports Second Quarter 2015 Financial Results and Operational HighlightsPrinter Friendly Version
08/04/15Fibrocell to Present at 2015 Wedbush PacGrow Healthcare ConferencePrinter Friendly Version
07/30/15Fibrocell to Report Second Quarter 2015 Financial and Operating Results, and Host Conference Call and Webcast on Thursday, August 6, 2015Printer Friendly Version
07/22/15Fibrocell Announces Pricing of Public Offering of Common StockPrinter Friendly Version
07/21/15Fibrocell Announces Proposed Public Offering of Common StockPrinter Friendly Version
07/20/15Fibrocell and Intrexon Announce IND Filing of FCX-007 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)Printer Friendly Version
06/29/15Fibrocell Joins the Russell 2000(R) IndexPrinter Friendly Version
06/08/15Fibrocell and Intrexon Announce Positive in vitro Pre-Clinical Data for FCX-007 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB) at European Society of Human GeneticsPrinter Friendly Version
06/01/15Fibrocell Appoints Michael F. Marino as Senior Vice President, General Counsel and Corporate SecretaryPrinter Friendly Version
05/28/15Fibrocell and Intrexon Announce Poster Presentation on FCX-007 for Recessive Dystrophic Epidermolysis Bullosa (RDEB) at the European Society of Human Genetics Annual Meeting 2015Printer Friendly Version
05/26/15Fibrocell to Present at Jefferies 2015 Global Healthcare ConferencePrinter Friendly Version
05/12/15Fibrocell Receives Rare Pediatric Disease Designation From FDA for FCX-007 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)Printer Friendly Version
05/08/15Fibrocell Science Reports First Quarter 2015 Financial and Operating ResultsPrinter Friendly Version
05/01/15Fibrocell Science to Report First Quarter 2015 Financial and Operating Results, and Host Conference Call and Webcast on Friday, May 8, 2015Printer Friendly Version
04/17/15Fibrocell Science to Present at World Orphan Drug Congress USA 2015Printer Friendly Version
03/18/15Fibrocell Science Appoints Keith A. Goldan, Senior Vice President and Chief Financial OfficerPrinter Friendly Version
03/13/15Fibrocell Science Reports Fourth Quarter and Full Year 2014 Financial and Operating ResultsPrinter Friendly Version
03/05/15Fibrocell Science to Report Fourth Quarter 2014 and Full Year 2014 Financial and Operating Results, and Host Conference Call and Webcast on March 13, 2015Printer Friendly Version
01/07/15Fibrocell Science to Present at Biotech Showcase 2015 ConferencePrinter Friendly Version



Printer Friendly Version E-mail this page RSS E-mail Alerts Download Financial Tear Sheet